He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
Strategic focus on COCO-model with a nationwide reach of 501 stores
The acquisition will strengthen the overall company’s position as leading global CRO services partner
he company will focus on production of any pharmaceutical and biotechnological products
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
He holds a Master’s in Management from the National University of Singapore
India has taken the lead in recognising NAFLD as a major non-communicable disease
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
This office will be the central hub for all operations related to companies ethical pharmaceutical business
Subscribe To Our Newsletter & Stay Updated
